TSS
OVID icon

Two Sigma Securities’s Ovid Therapeutics OVID Stock Holding History

Two Sigma Securities’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$192K Buy
71,487
+46,163
+182% +$119K 0.02% 1188
2026
Q1 		$56.2K Buy
+25,324
New +$45.3K 0.01% 1253
2025
Q4 		– Sell
-11,698
Closed -$15.2K – 1871
2025
Q3 		$15.2K Buy
+11,698
New +$10.1K ﹤0.01% 1170

Other funds holding OVID

JT
Jupiter Topco New York $245B AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Two Sigma Securities's OVID Position: Q2 2026 in Review

Two Sigma Securities increased its Ovid Therapeutics (OVID) stake by 182% in Q2 2026, buying an estimated $119K and bringing the position to 71,487 shares worth $192K. The position accounts for 0.02% of the portfolio, ranked #1188.

Two Sigma Securities first reported a position in OVID in Q3 2025 and has held it in 3 quarters since. 130 funds tracked by Wall St. Rank hold OVID as of Q2 2026.

  • Two Sigma Securities held 71,487 shares of Ovid Therapeutics worth $192K as of Q2 2026.
  • Two Sigma Securities bought 46,163 Ovid Therapeutics shares in Q2 2026, an estimated $119K.
  • Ovid Therapeutics made up 0.02% of Two Sigma Securities's portfolio in Q2 2026, its #1188 holding.
  • Two Sigma Securities first reported a position in Ovid Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 130 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.